It has been demonstrated that metformin can promote chondrocyte autophagy and reduce chondrocyte apoptosis through the AMPKα2/SIRT1 pathway to alleviate osteoarthritis, and the protective effect of metformin is reversed by silencing AMPKα2 or blocking SIRT1 expression (57). Here, PRKAA2 is linked to osteoarthritis.